Multiple hepatocellular carcinomas at the early stage have different clonality

Area of Science:

• Hepatology
• Oncology
• Molecular Biology

Background:

• The clonal origin of hepatocellular carcinoma (HCC), particularly multiple tumors, remains a subject of scientific debate.
• Investigating tumor clonality is crucial for understanding HCC pathogenesis and guiding treatment strategies.

Purpose of the Study:

• To evaluate the clonality of multiple hepatocellular carcinomas using DNA fingerprinting.
• To determine if multiple HCCs in the same patient share a common clonal origin.

Main Methods:

• DNA fingerprinting using HinfI digestion and gel electrophoresis.
• In-gel hybridization with a GTGGTGGTGGTGGTG oligonucleotide probe.
• Analysis of hepatitis B viral DNA integration patterns in HBsAg-positive patients.

Main Results:

• Seven out of nine HBsAg-positive patients exhibited tumors with distinct clonalities.
• Four out of nine HBsAg-negative patients displayed varied tumor band patterns via DNA fingerprinting.
• The findings suggest that multiple HCCs frequently originate from different clones.

Conclusions:

• Multiple hepatocellular carcinomas commonly possess different clonal origins.
• This heterogeneity underscores the importance of addressing underlying etiological factors in hepatocarcinogenesis.
• Further research into the clonal evolution of HCC is warranted.